Latest In: Epidiolex

Dravet syndrome ennox-Gastaut syndrome Epidiolex Epidyolex European Commission Germany NASDAQ United Kingdom
Image of European Union flags

European Commission approves Epidiolex marketing authorization, GW Pharmaceuticals says

The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In…

News September 23
Epidiolex GW Pharmaceuticals

GW Pharma’s cannabis drug OK’d by European Medicines Agency panel

GW Pharmaceuticals announced that the Committee for Medicinal Products for Human Use (CHMP) recommended approval of the British company’s…

News July 26
Epidiolex GW Pharmaceuticals medical marijuana Sativex

Epidiolex, Sativex maker GW Pharma reports Q1 revenue, loss improvement

United Kingdom-based GW Pharmaceuticals showed revenue of $39.2 million for the quarter ended March 31, 2019, compared with…

News May 6
Cesamet Dravet syndrome Epidiolex Lennox-Gastaut syndrome Marinol Ministry of Food and Drug Safety multiple sclerosis Sativex Singapore South Korea

South Korea’s medical cannabinoid law to go into effect in March

A groundbreaking law legalizing medical cannabis in South Korea that takes effect March 12 will pave the way for the…

News February 19
cbd dea Epidiolex GW Pharmaceuticals LeafLogix

DEA moves some CBD medicines off Schedule 1, a limited expansion of cannabis access

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that…

News September 27
Cesamet Epidiolex Israel Korean Cannabis Association Marinol Sativex South Korea Tikun Olam York Bridge Capital

‘Breakthrough’ in South Korea as cannabis law gets major backer

A move to legalize medical marijuana in South Korea picked up a key backer, increasing its chances of…

News July 24
Arizona marijuana cannabis extracts Epidiolex FDA CBD federal marijuana law U.S. Senate

Week in Review: FDA approves CBD drug, Arizona court bans marijuana extracts & federal cannabis reform

The FDA signs off on a cannabis-derived drug to treat epilepsy, an Arizona court says marijuana extracts are…

News June 29
dea Epidiolex FDA GW Pharmaceuticals

FDA approves cannabis-derived medicine; DEA must weigh in

The U.S. Food and Drug Administration has approved a CBD drug - a landmark decision that will trigger…

News June 25
Epidiolex GW Pharmaceuticals U.S. Food and Drug Administration

FDA advisory panel gives thumbs-up to CBD epilepsy treatment

A CBD treatment for epilepsy is closer to becoming the first cannabis medicine approved for the U.S. market.

News April 19
MJBizCon Logo